StockData
SSIINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

SS Innovations International, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.45−0.08 (-3.16%)

Close on Oct 19, 2026

Market cap
$513.09M
P/E (TTM)
–
Dividend yield
–

SS Innovations International, Inc. revenue by segment

By business segment

By product or service

RevenueFY2025FY2024FY2023FY2022% of revenueYoY
System sales$38.35M$19.46M$5.23M$1.39M90.3%+97.1%
Instrument sales$3.18M$942.55K$647.77K$41.32K7.5%+237.8%
Warranty sales$877.03K$177.52K––2.1%+394.1%
Lease income$70.91K$71.70K––0.2%-1.1%
Warranty Sales [Member]–$177.52K$1.77K$19.35K––

By region

RevenueFY2025FY2024FY2023FY2022% of revenueYoY
India$36.79M$19.08M$5.36M$1.44B86.6%+92.8%
Philippines$2.25M–––5.3%–
Indonesia$1.02M$595.90K––2.4%+70.4%
South America [Member]$1.01M$468.20K––2.4%+115.1%
Iraq$766.26K–––1.8%–
Cyprus$522.33K–––1.2%–
Oman$85.38K–––0.2%–
United Arab Emirates$31.26K–$512.50M–0.1%–
Nepal$18.71K$501.72K––0.0%-96.3%
AED––$512.50K–––

From the segment and revenue-disaggregation notes of SS Innovations International's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.